Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

186.46 -3.18 (-1.68%)
Streaming Delayed Price Updated: 1:07 PM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
5 Analysts Assess IQVIA Hldgs: What You Need To Know
 
Via Benzinga
IQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare”
From IQVIA
Via Business Wire
IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
From IQVIA
Via Business Wire
Analyst Scoreboard: 4 Ratings For IQVIA Hldgs
 
Via Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
 
Via Benzinga
Forecasting The Future: 8 Analyst Projections For IQVIA Hldgs
 
Via Benzinga
Peering Into IQVIA Hldgs's Recent Short Interest
 
Via Benzinga
IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses
From IQVIA
Via Business Wire
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades'
AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
From IQVIA
Via Business Wire
Peering Into IQVIA Hldgs's Recent Short Interest
 
Via Benzinga
How Is The Market Feeling About IQVIA Hldgs?
 
Via Benzinga
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024
IQV stock results show that IQVIA Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
IQVIA Reports First-Quarter 2024 Results
From IQVIA Holdings Inc.
Via Business Wire
Analysts Are Pounding the Table on These 3 Stocks: April 2024
From pharmaceutical testing to expansive integration expanding infrastructure, here are three stocks with analyst recommendations to buy. 
Via InvestorPlace
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
From IQVIA
Via Business Wire
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
From IQVIA Holdings Inc.
Via Business Wire
Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost
Salesforce shares rise after partnership with IQVIA to develop Life Sciences Cloud for customer engagement. 
Via Benzinga
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
From IQVIA
Via Business Wire
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. 
Via The Motley Fool
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Publishes its 2023 Environmental, Social and Governance Report
From IQVIA
Via Business Wire
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024
From IQVIA Holdings Inc.
Via Business Wire
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings. 
Via Benzinga
Topics Economy
Healthcare Analytics-Focused IQVIA Says 2023 Performance Solid Despite Challenging Macro Environment
IQVIA beats Q4 2023 sales expectations, reporting $3.87 billion (3.5% Y/Y). Adjusted EPS of $2.84 exceeds guidance. IQV's 2023 performance and optimistic 2024 outlook. 
Via Benzinga
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.